# Disrupting the Bone Marrow Microenvironment With G-CSF in Acute Lymphoblastic Leukemia

> **NCT01331590** · EARLY_PHASE1 · COMPLETED · sponsor: **Washington University School of Medicine** · enrollment: 13 (actual)

## Conditions studied

- Precursor Cell Lymphoblastic Leukemia-Lymphoma

## Interventions

- **DRUG:** G-CSF
- **DRUG:** Ifosfamide
- **DRUG:** Etoposide
- **DRUG:** Dexamethasone
- **DRUG:** Mesna

## Key facts

- **NCT ID:** NCT01331590
- **Lead sponsor:** Washington University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-07
- **Primary completion:** 2014-10
- **Final completion:** 2015-11
- **Target enrollment:** 13 (ACTUAL)
- **Last updated:** 2016-09-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01331590

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01331590, "Disrupting the Bone Marrow Microenvironment With G-CSF in Acute Lymphoblastic Leukemia". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01331590. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*